Medtech 360

October 2011

US Markets for Soft Tissue Repair Devices 2012


The market for soft tissue repair devices in the US has exhibited steady growth through the past several years, primarily due to the introduction of new and innovative products. Though overall growth for these markets will stabilize over the forecast period, several areas will nevertheless undergo notable market expansion. For example, biologic meshes in the ventral hernia repair (VHR) and inguinal hernia repair (IHR) device markets continue to witness increased adoption and product differentiation. In addition, synthetic absorbable meshes are beginning to compete for sales within the hernia market by offering the benefits of both biologics and nonabsorbable synthetic meshes. In the vaginal sling and pelvic floor reconstruction (PFR) device markets, on the other hand, the recent Food and Drug Administration (FDA) public health notification regarding adverse events associated with soft tissue repair devices for urogynecological indications will dampen growth prospects. This event has caused a notable drop in these markets, impacting overall market growth in the early part of the forecast period. Nonetheless, market drivers will ultimately outweigh market limiters, resulting in moderate growth in the soft tissue repair device market over the forecast period.

Questions Answered in This Report:

  *  The FDA's public health notification warning about the high incidence of adverse events associated with soft tissue repair devices used for urogynecological treatments will dampen demand for these products. How exactly will this notification impact different markets and segments within this market? What is the likelihood of these markets recovering? How will this impact the competitive landscape of the US market for soft tissue repair devices?

  *   Innovations in the hernia repair markets include the uptake of biologic meshes and synthetic absorbable meshes. What are the benefits of these products over competing meshes? How will the competitive landscape change in the coming years as a result of the adoption of these technologies?

  *   The competitive landscape in the rotator cuff reinforcement graft market has been relatively stable in recent years, particularly within the allograft and synthetic segments of the market. What strategies can current and new competitors in this market implement to accelerate growth?


Regions covered: US

Procedure segmentation: Our analysis uses the following breakdown of procedures:

  • VHR
    • Tension repair
    • Tension-free repair
      • Laparoscopic repair
      • Open repair
  • Vaginal sling procedures
    • Autologous
    • Commercial mesh
  • IHR
    • Tension repair
    • Tension-free repair
      • Open repair
      • Laparoscopic repair
  • PFR
    • With mesh
    • Without mesh
  • Rotator cuff reinforcement
    • Minor repair
    • Major repair
    • With reinforcement
    • Without reinforcement

Market segmentation: Our analysis uses the following breakdown of the market:

  • VHR
    • Synthetic
      • Standard meshes
      • Composite meshes
    • Biologic
      • Xenograft
      • Allograft
  • Vaginal slings
    • Transobturator slings
    • Single-incision slings
    • Other slings
  • IHR
    • Synthetic
      • Proprietary meshes
      • Flatsheet meshes
  • PFR
    • Synthetic
      • Kit
      • Single units
    • Biologic
      • Xenograft (kits and single units)
      • Allograft
  • Rotator cuff reinforcement grafts
    • Synthetic
    • Allograft
    • Xenograft
      • Porcine collagen
      • Bovine collagen
      • Equine collagen

Market forecast features: Based on primary research with industry professionals and key opinion leaders/end users, we use our proprietary forecasting model to provide an in-depth examination of current and future trends in procedure volumes, unit sales, average selling prices, and market values over a 7-year period (2010-2016).

Competitive analysis: We provide a detailed analysis of the competitive landscape in the market, as well as market shares and qualitative discussions of the leading competitors in each market segment.


Sohaib Perwaiz


Steven Edgar
Nancy Huynh
Thevaki Thevaratnam

Search Reports

Mentioned in this report:

  • American Medical Systems (AMS)
  • Arthrex
  • Artimplant
  • Atrium Medical
  • Biomet Sports Medicine
  • Boston Scientific
  • Brennen Medical
  • Caldera Medical
  • CL Medical
  • Coloplast
  • Cook Medical
  • Covidien
  • C. R. Bard
  • DePuy Orthopaedics
  • Endo Pharmaceuticals
  • Ethicon
  • Genzyme
  • Integra LifeSciences
  • LifeCell
  • LifeNet Health
  • Mpathy Medical (acquired by Coloplast)
  • Neomedic International
  • Novus Scientific
  • Promedon
  • Promethean Surgical Devices
  • ProSurg
  • Proxy Medical
  • Stryker
  • Synovis
  • TEI Biosciences
  • Tornier
  • TYRX
  • W. L. Gore
  • Wright Medical Technology
Decision Resources Group brands include: